MARKET NEWS

Inovio Develops Novel H3N2 Influenza DNA Vaccine; Generates Cross-Reactive Responses & Provides Complete Protection Against Lethal Preclinical Challenges
ContraVir Pharmaceuticals Announces Completion of Phase 1 With CRV431
Neurimmune Achieves Milestone in Collaboration With Ono Pharmaceutical
Lonza Launches Early-Intermediates Supply Initiative for Small-Molecule APIs
Beta Bionics Secures $50-Million Financing for Bionic Pancreas
ProMach Acquires FLtecnics, Leading Manufacturer of Horizontal-Form-Fill Seal Pouch Packaging Solutions

  FEATURED EDITORIAL

  COMPANY PROFILE

Pharmaceutical formulators continue to strive to create market leading products with maximum efficacy, quality, and performance. However, the inability to achieve API solubility and stability are common day-to-day challenges for formulators. With the help from Croda’s superior quality and ultrahigh purity specialty line of excipients, formulators are able to surpass these barriers, making Croda the supplier of choice in the global pharmaceutical market. With products being manufactured at multiple sites throughout the world, we are able to provide local and consistent supply of one of the widest ranges of chemical specialties, surfactants, and high-purity lipids available to the pharmaceutical industry. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Contract Manufacturing

Evonik Completes Multi-Million Dollar Expansion of its CMO Capabilities for API & Advanced Intermediates

Evonik, a global CMO leader for API and advanced intermediates, recently announced the completion of a 36-million euro expansion of its contract manufacturing capabilities in the US and Europe.

Molecular Templates Announces Agreement With Takeda for Joint Development of Protein-Based Oncology Therapy

Molecular Templates Announces Agreement With Takeda for Joint Development of Protein-Based Oncology Therapy

Molecular Templates, Inc. recently announced an agreement with Takeda Pharmaceutical Company Limited for the joint development of CD38-targeted engineered toxin bodies (ETBs) for the treatment of patients with diseases such as multiple myeloma.

Contract Services

Thermo Fisher Scientific to Launch Global Customer Solution Centers

Thermo Fisher Scientific Inc. recently announced its intent to open multiple Global Customer Solution Centers. The new Global Customer Solution Centers will focus on meeting and exceeding the demands of scientists in food, beverage, pharmaceutical and biotech laboratories by developing critical workflows and integrated solutions that help advance chromatography and mass spectrometry worldwide. 

PAREXEL Advances Patient-Centric Drug Development With Introduction of its Patient Innovation Center

PAREXEL Advances Patient-Centric Drug Development With Introduction of its Patient Innovation Center

PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, execution and market access. 

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

October 3 – Gene Therapy
October 10 – API Manufacturing